{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:59:07Z","timestamp":1789469947191,"version":"build-2803163510"},"reference-count":29,"publisher":"BMJ","issue":"20","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,4,12]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients with a systemic right ventricle (sRV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA (ccTGA) are prone to sRV dysfunction. Pharmacological options for sRV failure remain poorly defined. This study aims to investigate the tolerability and effects of sacubitril\/valsartan on sRV failure in adult patients with sRV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this two-centre, prospective cohort study, all consecutive adult patients with symptomatic heart failure and at least moderately reduced sRV systolic function were initiated on sacubitril\/valsartan and underwent structured follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data of 40 patients were included (40% female, 30% ccTGA, median age 48 (44\u201353) years). Five patients discontinued therapy during titration. Median follow-up was 24 (12\u201336) months. The maximal dose was tolerated by 49% of patients. No episodes of hyperkalaemia or renal function decline occurred. Six-minute walking distance increased significantly after 6 months of treatment (569\u00b116 to 597\u00b116 m, p=0.016). Serum N-terminal-prohormone brain natriuretic peptide (NT-proBNP) levels decreased significantly after 3 months (567 (374\u20131134) to 404 (226\u2013633) ng\/L, p&lt;0.001). Small, yet consistent echocardiographic improvements in sRV function were observed after 6 months (sRV global longitudinal strain: \u221211.1\u00b10.5% to \u221212.6\u00b10.7%, p&lt;0.001, and fractional area change: 20% (16%\u221224%) to 26% (19%\u221230%), p&lt;0.001). The linear mixed-effects model illustrated that after first follow-up moment, no time effect was present for the parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment with sacubitril\/valsartan was associated with a low rate of adverse effects in this adult sRV cohort. Persisting improvement in 6-minute walking test distance, NT-proBNP levels and echocardiographic parameters of sRV function was observed in an on-treatment analysis and showed no differential response based on sex or anatomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2022-322332","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:20:23Z","timestamp":1683811223000},"page":"1525-1532","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Tolerability and beneficial effects of sacubitril\/valsartan on systemic right ventricular failure"],"prefix":"10.1136","volume":"109","clinical-trial-number":[{"clinical-trial-number":"nct05117736","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4893-6575","authenticated-orcid":false,"given":"Marieke","family":"Nederend","sequence":"first","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippine","family":"Ki\u00e8s","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelien V","family":"Regeer","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert W","family":"Vliegen","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart JA","family":"Mertens","sequence":"additional","affiliation":[{"name":"Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Robbers-Visser","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-9692","authenticated-orcid":false,"given":"Berto J","family":"Bouma","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens F","family":"Tops","sequence":"additional","affiliation":[{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Schalij","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-0418","authenticated-orcid":false,"given":"Monique R M","family":"Jongbloed","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Anatomy & Embryology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9312-2338","authenticated-orcid":false,"given":"Anastasia D","family":"Egorova","sequence":"additional","affiliation":[{"name":"Center for Congenital Heart Disease Amsterdam Leiden (CAHAL), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Cardiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"2025092022200443000_109.20.1525.1","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.15829\/1560-4071-2021-4702","article-title":"2020 ESC guidelines for themanagement of adult congenital heart disease","volume":"26","author":"Baumgartner","year":"2020","journal-title":"Russ J Cardiol"},{"key":"2025092022200443000_109.20.1525.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu102"},{"key":"2025092022200443000_109.20.1525.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.010770"},{"key":"2025092022200443000_109.20.1525.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00682-3"},{"key":"2025092022200443000_109.20.1525.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092022200443000_109.20.1525.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)32100-X"},{"key":"2025092022200443000_109.20.1525.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.135392"},{"key":"2025092022200443000_109.20.1525.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.11.027"},{"key":"2025092022200443000_109.20.1525.9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.hlc.2018.12.003","article-title":"Sacubitril\/valsartan in adult congenital heart disease patients with chronic heart failure-a single centre case series and call for an international registry","volume":"29","author":"Appadurai","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2025092022200443000_109.20.1525.10","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/j.healun.2020.01.908","article-title":"Initial experience in adults with complex congenital heart disease treated with sacubitril\/valsartan for heart failure","volume":"39","author":"Goodwin","year":"2020","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"2025092022200443000_109.20.1525.11","doi-asserted-by":"publisher","DOI":"10.1177\/2150135119825599"},{"key":"2025092022200443000_109.20.1525.12","doi-asserted-by":"crossref","first-page":"100268","DOI":"10.1016\/j.ijcchd.2021.100268","article-title":"Sacubitril\/valsartan for heart failure in patients with complex adult congenital heart disease \u2013 experience from a tertiary centre in Singapore","volume":"6","author":"Yan","year":"2021","journal-title":"International Journal of Cardiology Congenital Heart Disease"},{"key":"2025092022200443000_109.20.1525.13","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-318074"},{"key":"2025092022200443000_109.20.1525.14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","article-title":"Safety and efficacy of sacubitril\/valsartan in patients with a failing systemic right ventricle: a prospective single-center study","volume":"16","author":"Fusco","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2025092022200443000_109.20.1525.15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ehjdh\/ztab028","article-title":"Potential of ehealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure","volume":"2","author":"Nederend","year":"2021","journal-title":"Eur Heart J Digit Health"},{"key":"2025092022200443000_109.20.1525.16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.644193","article-title":"Validation and feasibility of echocardiographic assessment of systemic right ventricular function: serial correlation with MRI","volume":"8","author":"Zandstra","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025092022200443000_109.20.1525.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"2025092022200443000_109.20.1525.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"2025092022200443000_109.20.1525.19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ehf2.13781","article-title":"Brisk walking can be a maximal effort in heart failure patients: a comparison of cardiopulmonary exercise and 6 min walking test cardiorespiratory data","volume":"9","author":"Mapelli","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2025092022200443000_109.20.1525.20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1047951105000818","article-title":"Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease","volume":"15","author":"Niedeggen","year":"2005","journal-title":"Cardiol Young"},{"key":"2025092022200443000_109.20.1525.21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013745","article-title":"Exploring the prognostic value of novel markers in adults with a systemic right ventricle","volume":"8","author":"Geenen","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025092022200443000_109.20.1525.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.931"},{"key":"2025092022200443000_109.20.1525.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.04.019"},{"key":"2025092022200443000_109.20.1525.24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","article-title":"Sex differences in heart failure","volume":"28","author":"Lala","year":"2022","journal-title":"J Card Fail"},{"key":"2025092022200443000_109.20.1525.25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ehjcvp\/pvaa111","article-title":"Medication in adults after atrial switch for transposition of the great arteries: clinical practice and recommendations","volume":"8","author":"Woudstra","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025092022200443000_109.20.1525.26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010063","article-title":"Calling for cooperation and collaboration in adult congenital heart disease-related heart failure","volume":"15","author":"Cedars","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2025092022200443000_109.20.1525.27","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.ijcchd.2021.100096","article-title":"The protocol and rationale for the efficacy and tolerability of sacubitril-valsartan in adult congenital heart disease patients with heart failure (ENTRUST ACHD HF) registry","volume":"3","author":"Appadurai","year":"2021","journal-title":"International Journal of Cardiology Congenital Heart Disease"},{"key":"2025092022200443000_109.20.1525.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)31871-6"},{"key":"2025092022200443000_109.20.1525.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-322332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T05:20:16Z","timestamp":1758432016000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-322332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":29,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,9,28]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/heartjnl-2022-322332"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-322332","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}